# Orlistat

## Xenical 120mg (42 capsules/box)

| TAH Drug Code      | [**OXEN**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OXEN)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Obesity management.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Dosing             | 120 mg 3 times daily with each main meal containing fat (during or up to 1 hour after the meal).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Chronic malabsorption syndrome, cholestasis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | Common Gastrointestinal: Abdominal discomfort, Abdominal pain (Up to 41.1% ), Defecation urgency (For up to 1 year, 22.1% to 38.9% ; for up to 2 years, 2.8% ), Discharge from anus, Oily (2.3% to 11.9% ), Flatulence (For up to 1 year, 23.9% to 43.9%; for up to 2 years, 2.1% ), Increased frequency of defecation (2.6% to 10.8% ), Soiling, Oily (For up to 1 year, 26.6% to 37.2% ; for up to 2 years, 4.4% ), Steatorrhea (For up to 1 year, 20%; for up to 2 years, 5.5% ) Musculoskeletal: Backache (13.9% ), Pain in lower limb (10.8% ) Neurologic: Headache (30.6% ) Respiratory: Upper respiratory infection (26.1% to 38.1% ) Other: Influenza (39.7% ) Serious Hepatic: Liver failure Renal: Nephrolithiasis, oxalate, Oxalate nephropathy, with renal failure |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

